Do you find our website to be helpful?
Yes   No

Clinical Trials


 

If you would like more information or are interested in our clinical trials please contact Marilyn, our trial director at (203) 365-6565.

Trial Director: Rebecca B. 
Contact: (203)787-6161

Alcon Research – 2015 to PRESENT – RTH Solution for Intravitreal Injection

Neovascular AMD
Rth258-C001

Chiltren - (2016 to 2017) – Squalamine Lactate Ophthalmic Solution

Neovasular AMD
OHR-1601

Opthotech – 2013 to 2016 - Fovista

Choroidal neovascularization secondary to AMD
OPH1002-AMD

Xoma Eye Guard – 2013 to 2015 – Gevokizumab

Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
XO52130/CL3-78989-005
XO52131/CL3-78989-006
X052132 – Rollover

Lux Biosciences 2011-2011 - Luminate

Treatment of Intermediate and Posterior Non-Infectious Uveitis

Alcon Pharmaceuticals 2010-2011 – Durezol vs Pred Forte

Treatment for Anterior Uveitis
1034 Phase III

Regeneron Pharmaceuticals 2008 – 2013 – Eylea

Neovascular AMD
VGTF-OD-0605 / View
VGTF-OD 0910

Allergan Pharmaceuticals 2006 – 2014 - Dexanmethasone

DME 206207-011
DME 206207-012
RVO 203207-009
Brimonidine GA 190342-032D

Genentech Pharmaceuticals 2004- 2013 – Lucentis

FVF4168g Ride Phase III - DME
FVF3192g Pier - AMD
FVF3689g Sailor – AMD

Eyetech Pharmaceuticals 2002- 2008 - Macugen

EOP 1003- AMD
EOP1006 - AMD
EOP1010 - AMD
EOP 1023 - DME

Our Locations

Choose your preferred location